Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates
CYTEK(CTKB) Zacks Investment Research·2024-05-09 08:31
Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of 0.05. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 80%. A quarter ago, it was expected that this company would post earnings of 0.07, delivering a surprise of 133.33%. Over the last four quarters, the co ...